CL2016002880A1 - Metodo - Google Patents

Metodo

Info

Publication number
CL2016002880A1
CL2016002880A1 CL2016002880A CL2016002880A CL2016002880A1 CL 2016002880 A1 CL2016002880 A1 CL 2016002880A1 CL 2016002880 A CL2016002880 A CL 2016002880A CL 2016002880 A CL2016002880 A CL 2016002880A CL 2016002880 A1 CL2016002880 A1 CL 2016002880A1
Authority
CL
Chile
Prior art keywords
lactamasas
preparacion
inhibidores
compuestos
proceso
Prior art date
Application number
CL2016002880A
Other languages
English (en)
Inventor
Andrea Faini
Marco Forzatti
Giovanni Fogliato
Stefano Biondi
Original Assignee
Allecra Therapeutics Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allecra Therapeutics Sas filed Critical Allecra Therapeutics Sas
Publication of CL2016002880A1 publication Critical patent/CL2016002880A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1896—Compounds having one or more Si-O-acyl linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/87—Compounds being unsubstituted in position 3 or with substituents other than only two methyl radicals attached in position 3, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

<p>Un método de formación de un compuesto de fórmula (IIIa);donde:R1 en cada ocurrencia se selecciona independientemente de H, halógeno, amino, alquilo de C1-5,alquenilo de C1-5 y alquinilo de C1-5;R2 en cada ocurrencia se selecciona independientemente de H,halógeno,amino, alquilo de C1-5, alquenilo de C1-5 y alquinilo de C1-5; R4 es alquilo de C1-5; y R6 es un fluoroalquilo de C1-5;y PG es un grupo protector;el método comprende el paso de hacer reaccionar un compuesto (IIa) con un compuesto (VIII).</p>
CL2016002880A 2014-05-15 2016-11-11 Metodo CL2016002880A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1408649.0A GB201408649D0 (en) 2014-05-15 2014-05-15 Method

Publications (1)

Publication Number Publication Date
CL2016002880A1 true CL2016002880A1 (es) 2017-06-16

Family

ID=51134924

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2016002880A CL2016002880A1 (es) 2014-05-15 2016-11-11 Metodo
CL2018001961A CL2018001961A1 (es) 2014-05-15 2018-07-19 Procedimiento de preparación de derivados de metil-penam (divisional solicitud 201602880)

Family Applications After (1)

Application Number Title Priority Date Filing Date
CL2018001961A CL2018001961A1 (es) 2014-05-15 2018-07-19 Procedimiento de preparación de derivados de metil-penam (divisional solicitud 201602880)

Country Status (29)

Country Link
US (1) US9963465B2 (es)
EP (3) EP3231806B1 (es)
JP (1) JP6613303B2 (es)
KR (1) KR102329186B1 (es)
CN (1) CN106459086B (es)
AU (1) AU2015261416B2 (es)
BR (1) BR112016026074B1 (es)
CA (1) CA2945900C (es)
CL (2) CL2016002880A1 (es)
CR (1) CR20160580A (es)
CY (2) CY1120957T1 (es)
DK (2) DK3143028T3 (es)
EA (2) EA201991629A3 (es)
EC (1) ECSP16085143A (es)
ES (2) ES2725675T3 (es)
GB (1) GB201408649D0 (es)
HR (2) HRP20182065T1 (es)
HU (1) HUE044511T2 (es)
IL (1) IL248834B (es)
LT (2) LT3143028T (es)
MX (1) MX378875B (es)
PE (1) PE20161433A1 (es)
PL (2) PL3231806T3 (es)
PT (2) PT3231806T (es)
RS (2) RS58430B1 (es)
SG (1) SG11201609494YA (es)
SI (2) SI3231806T1 (es)
TR (1) TR201906867T4 (es)
WO (1) WO2015173378A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201319776D0 (en) * 2013-11-08 2013-12-25 Allecra Therapeutics Sas Compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1319776A (en) 1969-07-15 1973-06-06 Yorkshire Chemicals Ltd Basic dyes
US7687488B2 (en) 2006-07-12 2010-03-30 Orchid Chemicals & Pharmaceuticals Ltd. 2-substituted methyl penam derivatives
NZ610247A (en) 2010-11-25 2014-09-26 Allecra Therapeutics Gmbh Β-lactamase inhibitors and their use
KR20120067257A (ko) * 2010-12-15 2012-06-25 서강대학교산학협력단 3-메틸-1,4-치환된 1,2,3-트라이아졸륨 기반의 이온성 액체 및 그의 제조방법과 응용

Also Published As

Publication number Publication date
EP3143028B1 (en) 2018-09-26
PT3143028T (pt) 2018-12-17
CL2018001961A1 (es) 2018-08-31
PT3231806T (pt) 2019-05-30
US9963465B2 (en) 2018-05-08
DK3231806T3 (da) 2019-05-20
CN106459086B (zh) 2018-11-13
EP3441395A1 (en) 2019-02-13
AU2015261416B2 (en) 2019-07-11
SI3231806T1 (sl) 2019-06-28
EP3231806A1 (en) 2017-10-18
DK3143028T3 (da) 2019-01-02
WO2015173378A2 (en) 2015-11-19
KR102329186B1 (ko) 2021-11-22
PL3143028T3 (pl) 2019-04-30
EA201991629A2 (ru) 2019-12-30
SI3143028T1 (sl) 2019-01-31
CN106459086A (zh) 2017-02-22
BR112016026074B1 (pt) 2023-01-03
HUE044511T2 (hu) 2019-10-28
GB201408649D0 (en) 2014-07-02
EA201991629A3 (ru) 2020-02-28
BR112016026074A8 (pt) 2021-03-30
EA201692306A1 (ru) 2017-05-31
PE20161433A1 (es) 2017-01-18
CY1120957T1 (el) 2019-12-11
SG11201609494YA (en) 2016-12-29
PL3231806T3 (pl) 2019-08-30
RS58748B1 (sr) 2019-06-28
KR20170002466A (ko) 2017-01-06
WO2015173378A3 (en) 2016-01-14
MX378875B (es) 2025-03-11
CA2945900C (en) 2023-01-24
JP2017515907A (ja) 2017-06-15
RS58430B1 (sr) 2019-04-30
CA2945900A1 (en) 2015-11-19
TR201906867T4 (tr) 2019-05-21
CR20160580A (es) 2017-05-09
ES2725675T3 (es) 2019-09-26
ECSP16085143A (es) 2017-05-31
ES2699644T3 (es) 2019-02-12
HRP20190830T1 (hr) 2019-06-28
LT3231806T (lt) 2019-05-27
MX2016014644A (es) 2017-02-23
EP3231806B1 (en) 2019-02-13
EP3143028A2 (en) 2017-03-22
HRP20182065T1 (hr) 2019-02-08
CY1121756T1 (el) 2020-07-31
EA033494B1 (ru) 2019-10-31
JP6613303B2 (ja) 2019-11-27
NZ725121A (en) 2023-09-29
AU2015261416A1 (en) 2016-11-10
IL248834A0 (en) 2017-01-31
US20170101421A1 (en) 2017-04-13
IL248834B (en) 2019-05-30
LT3143028T (lt) 2018-12-27

Similar Documents

Publication Publication Date Title
PH12019502252A1 (en) Gip receptor activating peptide
CY1120188T1 (el) ΠΑΡΑΓΩΓΑ ΝΑΦΘΥΡΙΔΙΝΗΣ ΧΡΗΣΙΜΑ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ ΙΝΤΕΓΚΡΙΝΗΣ αvβ6
MX2018003130A (es) Compuestos de heteroarilo como inhibidores de cinasas asociadas a receptor de interleucina-1 (irak) y usos de los mismos.
MX2017011821A (es) Silanos y composiciones curables que contienen dichos silanos como reticulantes.
MX2018012085A (es) Compuestos agonistas de gpr119 y metodo para tratar enfermedades y afecciones mediado a traves de gpr119.
CO2017012594A2 (es) Moduladores de receptor nuclear
CR20140306A (es) Fluormetil -5,6-dihidro-4h-[1,3] oxazinas
CR20190268A (es) Nuevos deribados de isoxazolil éter como pam de gaba a alfa5
MX2020013630A (es) Analogos de rapamicina y usos de los mismos.
MX377330B (es) Método para producir sales de biguanida y s-triazinas.
BR112018073100A2 (pt) material luminescente
EA201991241A1 (ru) Способ получения метоксиметилпиридин дикарбоксилата
MX387796B (es) Compuestos de aminocarbonilcarbamato.
EA201892449A1 (ru) Конденсированные гетероциклические соединения
MX2020003921A (es) Proceso para producir compuestos de tipo piridazinona herbicidas.
CY1120763T1 (el) Νεες ενωσεις σουλφονυλαμινοβενζαμιδιου
EA201990238A1 (ru) ФОСФОРСОДЕРЖАЩИЕ ПРОЛЕКАРСТВА СТИМУЛЯТОРОВ sGC
EA201891808A1 (ru) Трис-амидные соединения и композиции, содержащие их
MX2018003903A (es) Compuesto biciclico y uso del mismo para inhibicion de suv39h2.
CO2017003830A2 (es) Compuestos de piridina
BR112017005645A2 (pt) método de preparar cinamaldeído
ECSP16085143A (es) Metodo
CY1124594T1 (el) Καινοφανης πολυμορφικη μορφη της υδροχλωρικης ν-[2-(6-φθορο-lη-ινδολ-3-υλ)αιθυλ]-3-(2,2,3,3-τετραφθοροπροποξυ)βενζυλαμινης για την αγωγη της αλτσχαϊμεp
MX2020003922A (es) Proceso para producir compuestos de piridazinona herbicida.
DK3410556T3 (da) Styringsfremgangsmåde til beskyttelse af generatorer